Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Asthma-Related Emergency Department Visits Among Low-Income Families With Young Children by Race/Ethnicity and Primary Language.

Aratani Y, Nguyen HA, Sharma V.

Pediatr Emerg Care. 2019 Jan 21. doi: 10.1097/PEC.0000000000001430. [Epub ahead of print]

PMID:
30672895
2.

Association between emergency department utilization and the risk of child maltreatment in young children.

Kuang X, Aratani Y, Li G.

Inj Epidemiol. 2018 Dec 20;5(1):46. doi: 10.1186/s40621-018-0176-5.

3.

Correction to: The Prevalence of Mental Illness and Substance Abuse Among Rural Latino Adults with Multiple Adverse Childhood Experiences in California.

Barrera I, Sharma V, Aratani Y.

J Immigr Minor Health. 2019 Oct;21(5):977. doi: 10.1007/s10903-018-0825-3.

PMID:
30219983
4.

The Prevalence of Mental Illness and Substance Abuse Among Rural Latino Adults with Multiple Adverse Childhood Experiences in California.

Barrera I, Sharma V, Aratani Y.

J Immigr Minor Health. 2019 Oct;21(5):971-976. doi: 10.1007/s10903-018-0811-9. Erratum in: J Immigr Minor Health. 2018 Sep 15;:.

PMID:
30132162
5.

Dual Food and Energy Hardship and Associated Child Behavior Problems.

Fernández CR, Yomogida M, Aratani Y, Hernández D.

Acad Pediatr. 2018 Nov - Dec;18(8):889-896. doi: 10.1016/j.acap.2018.07.002. Epub 2018 Jul 11.

PMID:
30006124
6.

Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function.

Aratani Y.

Arch Biochem Biophys. 2018 Feb 15;640:47-52. doi: 10.1016/j.abb.2018.01.004. Epub 2018 Jan 11. Review.

PMID:
29336940
7.

Synthesis and evaluation of a potent, well-balanced EP2/EP3 dual agonist.

Kinoshita A, Higashino M, Yoshida K, Aratani Y, Kakuuchi A, Hanada K, Takeda H, Naganawa A, Matsuya H, Ohmoto K.

Bioorg Med Chem. 2018 Jan 1;26(1):200-214. doi: 10.1016/j.bmc.2017.11.035. Epub 2017 Nov 24.

PMID:
29203142
8.

Involvement of pentraxin-3 in anti-neutrophil cytoplasmic antibody production induced by aluminum salt adjuvant.

Nagai K, Aratani Y, Shibuya A, Yamagata K.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):735-738. Epub 2017 Aug 28.

PMID:
28850023
9.

Dual function photocatalysis of cyano-bridged heteronuclear metal complexes for water oxidation and two-electron reduction of dioxygen to produce hydrogen peroxide as a solar fuel.

Aratani Y, Suenobu T, Ohkubo K, Yamada Y, Fukuzumi S.

Chem Commun (Camb). 2017 Mar 25;53(24):3473-3476. doi: 10.1039/c7cc00621g. Epub 2017 Mar 8.

PMID:
28271095
10.

Myeloperoxidase deficiency enhances zymosan phagocytosis associated with up-regulation of surface expression of CD11b in mouse neutrophils.

Fujimoto K, Motowaki T, Tamura N, Aratani Y.

Free Radic Res. 2016 Dec;50(12):1340-1349. Epub 2016 Nov 2.

PMID:
27701922
11.

Genetic Phagocyte NADPH Oxidase Deficiency Enhances Nonviable Candida albicans-Induced Inflammation in Mouse Lungs.

Endo D, Fujimoto K, Hirose R, Yamanaka H, Homme M, Ishibashi KI, Miura N, Ohno N, Aratani Y.

Inflammation. 2017 Feb;40(1):123-135. doi: 10.1007/s10753-016-0461-9.

PMID:
27785664
12.

Housing hardship and energy insecurity among native-born and immigrant low-income families with children in the United States.

Hernández D, Jiang Y, Carrión D, Phillips D, Aratani Y.

J Child Poverty. 2016;22(2):77-92. Epub 2016 Mar 7.

13.

The potential for repositioning antithyroid agents as antiasthma drugs.

Suzuki S, Ogawa M, Ohta S, Arima K, Nunomura S, Nanri Y, Mitamura Y, Yoshihara T, Nakamura Y, Yamauchi K, Chibana K, Ishii Y, Lee JJ, Aratani Y, Kakuta S, Kubo S, Iwakura Y, Yoshida H, Izuhara K.

J Allergy Clin Immunol. 2016 Nov;138(5):1458-1461.e8. doi: 10.1016/j.jaci.2016.04.047. Epub 2016 Jun 15. No abstract available.

PMID:
27444178
14.

Photocatalytic Hydroxylation of Benzene by Dioxygen to Phenol with a Cyano-Bridged Complex Containing Fe(II) and Ru(II) Incorporated in Mesoporous Silica-Alumina.

Aratani Y, Oyama K, Suenobu T, Yamada Y, Fukuzumi S.

Inorg Chem. 2016 Jun 20;55(12):5780-6. doi: 10.1021/acs.inorgchem.5b02909. Epub 2016 Jun 6.

PMID:
27265780
15.

Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.

Kinoshita A, Higashino M, Aratani Y, Kakuuchi A, Matsuya H, Ohmoto K.

Bioorg Med Chem Lett. 2016 Feb 1;26(3):1016-1019. doi: 10.1016/j.bmcl.2015.12.039. Epub 2015 Dec 12.

PMID:
26725951
16.

Myeloperoxidase negatively regulates the expression of proinflammatory cytokines and chemokines by zymosan-induced mouse neutrophils.

Endo D, Saito T, Umeki Y, Suzuki K, Aratani Y.

Inflamm Res. 2016 Feb;65(2):151-9. doi: 10.1007/s00011-015-0899-5. Epub 2015 Nov 14.

PMID:
26573963
17.

English Proficiency, Threshold Language Policy and Mental Health Service Utilization among Asian-American Children.

Aratani Y, Liu CH.

Arch Psychiatr Nurs. 2015 Oct;29(5):326-32. doi: 10.1016/j.apnu.2015.06.006. Epub 2015 Jun 18.

PMID:
26397437
18.

Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.

Itadani S, Yashiro K, Aratani Y, Sekiguchi T, Kinoshita A, Moriguchi H, Ohta N, Takahashi S, Ishida A, Tajima Y, Hisaichi K, Ima M, Ueda J, Egashira H, Sekioka T, Kadode M, Yonetomi Y, Nakao T, Inoue A, Nomura H, Kitamine T, Fujita M, Nabe T, Yamaura Y, Matsumura N, Imagawa A, Nakayama Y, Takeuchi J, Ohmoto K.

J Med Chem. 2015 Aug 13;58(15):6093-113. doi: 10.1021/acs.jmedchem.5b00741. Epub 2015 Jul 22.

PMID:
26200813
19.

The voltage-gated proton channel Hv1/VSOP inhibits neutrophil granule release.

Okochi Y, Aratani Y, Adissu HA, Miyawaki N, Sasaki M, Suzuki K, Okamura Y.

J Leukoc Biol. 2016 Jan;99(1):7-19. doi: 10.1189/jlb.3HI0814-393R. Epub 2015 May 19.

PMID:
25990245
20.

Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid.

Itadani S, Takahashi S, Ima M, Sekiguchi T, Aratani Y, Egashira H, Matsumura N, Inoue A, Yonetomi Y, Fujita M, Nakayama Y, Takeuchi J.

Bioorg Med Chem. 2015 May 1;23(9):2079-97. doi: 10.1016/j.bmc.2015.03.011. Epub 2015 Mar 7.

PMID:
25800431
21.

Selective hydroxylation of benzene derivatives and alkanes with hydrogen peroxide catalysed by a manganese complex incorporated into mesoporous silica-alumina.

Aratani Y, Yamada Y, Fukuzumi S.

Chem Commun (Camb). 2015 Mar 18;51(22):4662-5. doi: 10.1039/c4cc09967b.

PMID:
25692189
22.

The Effects of Runaway-Homeless Episodes on High School Dropout.

Aratani Y, Cooper JL.

Youth Soc. 2015 Mar;47(2):173-198.

23.

Children's mental health policies in the United States: perspectives from advocates and state leaders.

Cooper JL, Aratani Y.

Health Expect. 2015 Dec;18(6):2213-22. doi: 10.1111/hex.12191. Epub 2014 Apr 3.

24.
25.

Myeloperoxidase deficiency in mice exacerbates lung inflammation induced by nonviable Candida albicans.

Homme M, Tateno N, Miura N, Ohno N, Aratani Y.

Inflamm Res. 2013 Nov;62(11):981-90. doi: 10.1007/s00011-013-0656-6. Epub 2013 Aug 18.

PMID:
23955550
26.

Myeloperoxidase deficiency induces MIP-2 production via ERK activation in zymosan-stimulated mouse neutrophils.

Tateno N, Matsumoto N, Motowaki T, Suzuki K, Aratani Y.

Free Radic Res. 2013 May;47(5):376-85. doi: 10.3109/10715762.2013.778990. Epub 2013 Mar 22.

PMID:
23438680
27.

[Role of neutrophil-derived reactive oxygen species in host defense and inflammation].

Aratani Y, Miura N, Ohno N, Suzuki K.

Med Mycol J. 2012;53(2):123-8. Review. Japanese.

28.

The economic impact of adolescent health promotion policies and programs.

Aratani Y, Schwarz SW, Skinner C.

Adolesc Med State Art Rev. 2011 Dec;22(3):367-86, ix. Review.

PMID:
22423456
29.

Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury.

Kubota K, Saiwai H, Kumamaru H, Maeda T, Ohkawa Y, Aratani Y, Nagano T, Iwamoto Y, Okada S.

Spine (Phila Pa 1976). 2012 Jul 15;37(16):1363-9. doi: 10.1097/BRS.0b013e31824b9e77.

PMID:
22322369
30.

Contribution of neutrophil-derived myeloperoxidase in the early phase of fulminant acute respiratory distress syndrome induced by influenza virus infection.

Sugamata R, Dobashi H, Nagao T, Yamamoto K, Nakajima N, Sato Y, Aratani Y, Oshima M, Sata T, Kobayashi K, Kawachi S, Nakayama T, Suzuki K.

Microbiol Immunol. 2012 Mar;56(3):171-82. doi: 10.1111/j.1348-0421.2011.00424.x.

31.

Severe neutrophil-mediated lung inflammation in myeloperoxidase-deficient mice exposed to zymosan.

Takeuchi K, Umeki Y, Matsumoto N, Yamamoto K, Yoshida M, Suzuki K, Aratani Y.

Inflamm Res. 2012 Mar;61(3):197-205. doi: 10.1007/s00011-011-0401-y. Epub 2011 Nov 25.

PMID:
22116298
32.

Racial and ethnic disparities in the continuation of community-based children's mental health services.

Aratani Y, Cooper JL.

J Behav Health Serv Res. 2012 Apr;39(2):116-29. doi: 10.1007/s11414-011-9261-z.

PMID:
22076314
33.

Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells.

Phung TT, Sugamata R, Uno K, Aratani Y, Ozato K, Kawachi S, Thanh Nguyen L, Nakayama T, Suzuki K.

Microbiol Immunol. 2011 Dec;55(12):874-84. doi: 10.1111/j.1348-0421.2011.00396.x.

34.

Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody.

Nagao T, Suzuki K, Utsunomiya K, Matsumura M, Saiga K, Wang PC, Minamitani H, Aratani Y, Nakayama T, Suzuki K.

Nephrol Dial Transplant. 2011 Sep;26(9):2752-60. doi: 10.1093/ndt/gfr032. Epub 2011 Mar 5.

PMID:
21378392
35.

Examining the landscape of child poverty in the US today.

Wight VR, Chau M, Thampi K, Aratani Y.

Curr Probl Pediatr Adolesc Health Care. 2010 Nov;40(10):263-6. doi: 10.1016/j.cppeds.2010.08.003. No abstract available.

PMID:
21051023
36.

Formation of cholesterol ozonolysis products in vitro and in vivo through a myeloperoxidase-dependent pathway.

Tomono S, Miyoshi N, Shiokawa H, Iwabuchi T, Aratani Y, Higashi T, Nukaya H, Ohshima H.

J Lipid Res. 2011 Jan;52(1):87-97. doi: 10.1194/jlr.M006775. Epub 2010 Oct 4.

37.

Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation.

Asahi T, Kondo H, Masuda M, Nishino H, Aratani Y, Naito Y, Yoshikawa T, Hisaka S, Kato Y, Osawa T.

J Biol Chem. 2010 Mar 19;285(12):9282-91. doi: 10.1074/jbc.M109.054213. Epub 2010 Jan 15.

38.

The status of states' policies to support evidence-based practices in children's mental health.

Cooper JL, Aratani Y.

Psychiatr Serv. 2009 Dec;60(12):1672-5. doi: 10.1176/ps.2009.60.12.1672.

PMID:
19952159
39.

Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production.

Haegens A, Heeringa P, van Suylen RJ, Steele C, Aratani Y, O'Donoghue RJ, Mutsaers SE, Mossman BT, Wouters EF, Vernooy JH.

J Immunol. 2009 Jun 15;182(12):7990-6. doi: 10.4049/jimmunol.0800377.

40.

Development of thermotolerance requires interaction between polymerase-beta and heat shock proteins.

Takahashi A, Yamakawa N, Mori E, Ohnishi K, Yokota S, Sugo N, Aratani Y, Koyama H, Ohnishi T.

Cancer Sci. 2008 May;99(5):973-8. doi: 10.1111/j.1349-7006.2008.00759.x.

41.

Activation of inducible nitric oxide synthase increases MMP-2 and MMP-9 levels in ApoE-knockout mice.

Chen Y, Aratani Y, Osawa T, Fukuyama N, Tsuji C, Nakazawa H.

Tokai J Exp Clin Med. 2008 Apr 20;33(1):28-34.

42.

Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion.

Matthijsen RA, Huugen D, Hoebers NT, de Vries B, Peutz-Kootstra CJ, Aratani Y, Daha MR, Tervaert JW, Buurman WA, Heeringa P.

Am J Pathol. 2007 Dec;171(6):1743-52. Epub 2007 Nov 30.

43.
44.

Decreased PARP-1 levels accelerate embryonic lethality but attenuate neuronal apoptosis in DNA polymerase beta-deficient mice.

Sugo N, Niimi N, Aratani Y, Masutani M, Suzuki H, Koyama H.

Biochem Biophys Res Commun. 2007 Mar 16;354(3):656-61. Epub 2007 Jan 11.

PMID:
17257586
45.

[Role of myeloperoxidase in the host defense against fungal infection].

Aratani Y.

Nihon Ishinkin Gakkai Zasshi. 2006;47(3):195-9. Review. Japanese.

46.

Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans.

Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Ishida-Okawara A, Suzuki K, Maeda N, Koyama H.

J Med Microbiol. 2006 Sep;55(Pt 9):1291-9.

PMID:
16914663
47.

Further optimization of sulfonamide analogs as EP1 receptor antagonists: synthesis and evaluation of bioisosteres for the carboxylic acid group.

Naganawa A, Matsui T, Ima M, Saito T, Murota M, Aratani Y, Kijima H, Yamamoto H, Maruyama T, Ohuchida S, Nakai H, Toda M.

Bioorg Med Chem. 2006 Nov 1;14(21):7121-37. Epub 2006 Aug 1.

PMID:
16879970
48.
49.

Myeloperoxidase accumulates at the neutrophil surface and enhances cell metabolism and oxidant release during pregnancy.

Kindzelskii AL, Clark AJ, Espinoza J, Maeda N, Aratani Y, Romero R, Petty HR.

Eur J Immunol. 2006 Jun;36(6):1619-28.

50.

IFN-gamma primes RAW264 macrophages and human monocytes for enhanced oxidant production in response to CpG DNA via metabolic signaling: roles of TLR9 and myeloperoxidase trafficking.

Adachi Y, Kindzelskii AL, Petty AR, Huang JB, Maeda N, Yotsumoto S, Aratani Y, Ohno N, Petty HR.

J Immunol. 2006 Apr 15;176(8):5033-40.

Supplemental Content

Loading ...
Support Center